Krsnaa Diagnostics Limited

BSE:543328 Stock Report

Market Cap: ₹29.9b

Krsnaa Diagnostics Valuation

Is 543328 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 543328 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 543328 (₹926.7) is trading below our estimate of fair value (₹1973.02)

Significantly Below Fair Value: 543328 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 543328?

Key metric: As 543328 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 543328. This is calculated by dividing 543328's market cap by their current earnings.
What is 543328's PE Ratio?
PE Ratio43.2x
Earnings₹692.15m
Market Cap₹29.90b

Price to Earnings Ratio vs Peers

How does 543328's PE Ratio compare to its peers?

The above table shows the PE ratio for 543328 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average64.1x
526783 Dr. Agarwal's Eye Hospital
46.5xn/a₹23.5b
539871 Thyrocare Technologies
62x26.9%₹52.0b
VIJAYA Vijaya Diagnostic Centre
78.1x25.4%₹103.6b
METROPOLIS Metropolis Healthcare
70x23.8%₹103.6b
543328 Krsnaa Diagnostics
43.2x35.5%₹29.9b

Price-To-Earnings vs Peers: 543328 is good value based on its Price-To-Earnings Ratio (43.2x) compared to the peer average (64.1x).

Price to Earnings Ratio vs Industry

How does 543328's PE Ratio compare vs other companies in the IN Healthcare Industry?

3 CompaniesPrice / EarningsEstimated GrowthMarket Cap
523696 Fortis Malar Hospitals
2.1xn/aUS$11.79m
516110 Family Care Hospitals
3.3xn/aUS$4.41m
542918 Gian Life Care
5xn/aUS$2.35m
No more companies available in this PE range
543328 43.2xIndustry Avg. 42.3xNo. of Companies6PE020406080100+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 543328 is expensive based on its Price-To-Earnings Ratio (43.2x) compared to the Indian Healthcare industry average (42.3x).

Price to Earnings Ratio vs Fair Ratio

What is 543328's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

543328 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio43.2x
Fair PE Ratio64.3x

Price-To-Earnings vs Fair Ratio: 543328 is good value based on its Price-To-Earnings Ratio (43.2x) compared to the estimated Fair Price-To-Earnings Ratio (64.3x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 543328 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current₹926.70
₹983.67
+6.1%
10.5%₹1,084.00₹841.00n/a3
Nov ’25₹944.85
₹940.67
-0.4%
8.1%₹1,026.00₹841.00n/a3
Oct ’25₹853.45
₹892.00
+4.5%
5.3%₹955.00₹841.00n/a3
Sep ’25₹722.95
₹892.00
+23.4%
5.3%₹955.00₹841.00n/a3
Aug ’25₹677.40
₹927.00
+36.8%
6.6%₹970.00₹841.00n/a3
Jul ’25₹609.95
₹927.00
+52.0%
6.6%₹970.00₹841.00n/a3
May ’25₹575.35
₹952.00
+65.5%
1.8%₹969.00₹935.00n/a2
Apr ’25₹631.50
₹951.50
+50.7%
1.7%₹968.00₹935.00n/a2
Mar ’25₹665.85
₹951.50
+42.9%
1.7%₹968.00₹935.00n/a2
Feb ’25₹717.80
₹923.50
+28.7%
9.4%₹1,010.00₹837.00n/a2
Jan ’25₹706.45
₹923.50
+30.7%
9.4%₹1,010.00₹837.00n/a2
Dec ’24₹662.35
₹923.50
+39.4%
9.4%₹1,010.00₹837.00n/a2
Nov ’24₹699.35
₹995.50
+42.3%
5.5%₹1,050.00₹941.00₹944.852
Oct ’24₹681.75
₹995.50
+46.0%
5.5%₹1,050.00₹941.00₹853.452
Sep ’24₹643.55
₹995.50
+54.7%
5.5%₹1,050.00₹941.00₹722.952

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

Medico Intercontinental

₹506.6m

Trades in pharmaceutical products.

539938

₹50.66

7D

11.8%

1Y

-40.7%

Dr Lalchandani Labs

₹74.3m

Provides diagnostic and related healthcare tests and services in India.

541299

₹17.15

7D

-4.7%

1Y

-51.0%

N G Industries

₹544.1m

Provides various healthcare services in India.

530897

₹162.40

7D

-0.6%

1Y

-6.1%